Literature DB >> 27529905

Applications To Become Registered Under the Controlled Substances Act To Manufacture Marijuana To Supply Researchers in the United States. Policy statement.

.   

Abstract

To facilitate research involving marijuana and its chemical constituents, DEA is adopting a new policy that is designed to increase the number of entities registered under the Controlled Substances Act (CSA) to grow (manufacture) marijuana to supply legitimate researchers in the United States. This policy statement explains how DEA will evaluate applications for such registration consistent with the CSA and the obligations of the United States under the applicable international drug control treaty.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27529905

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  5 in total

1.  Questioning the New Drug Enforcement Administration Proposed Rule to Facilitate the Cultivation of Cannabis for Research Purposes.

Authors:  Agnes Balla; Donald I Abrams
Journal:  Cannabis Cannabinoid Res       Date:  2020-09-02

2.  Regulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path Forward.

Authors:  Daniele Piomelli; Robert Solomon; Donald Abrams; Agnes Balla; Igor Grant; Thomas Marcotte; John Yoder
Journal:  Cannabis Cannabinoid Res       Date:  2019-03

Review 3.  Marijuana Use and Organ Transplantation: a Review and Implications for Clinical Practice.

Authors:  Harinder Singh Rai; Gerald Scott Winder
Journal:  Curr Psychiatry Rep       Date:  2017-10-27       Impact factor: 5.285

4.  Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function.

Authors:  Staci A Gruber; Kelly A Sagar; Mary K Dahlgren; Megan T Racine; Rosemary T Smith; Scott E Lukas
Journal:  Front Pharmacol       Date:  2016-10-13       Impact factor: 5.810

Review 5.  Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States.

Authors:  Alice Mead
Journal:  Front Plant Sci       Date:  2019-06-14       Impact factor: 5.753

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.